Associations of IL-18 with Altered Cardiovascular Risk Profile in Psoriatic Arthritis and Ankylosing Spondylitis

Objective: To investigate the associations of IL-18 serum levels with serum lipids, cardiovascular risk, and disease activity in patients with ankylosing spondylitis (AS) and psoriatic arthritis (PsA) with axial (axPsA) and peripheral (perPsA) joint involvement. Methods: 155 adult patients (PsA 61/A...

Full description

Bibliographic Details
Main Authors:	Krzysztof Bonek, Ewa Kuca-Warnawin, Anna Kornatka, Agnieszka Zielińska, Małgorzata Wisłowska, Ewa Kontny, Piotr Głuszko
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Journal of Clinical Medicine
Subjects:	cardiovascular risk psoriatic arthritis dyslipidemia IL-18 spondyloarthropathies
Online Access:	https://www.mdpi.com/2077-0383/11/3/766

Similar Items

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
by: Krzysztof Bonek, et al.
Published: (2022-04-01)

Clinical profile of patients with psoriatic arthritis in a tertiary healthcare center
by: Ilyas Baig, et al.
Published: (2022-07-01)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
by: Lubrano E, et al.
Published: (2016-10-01)

Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis
by: Sueli Carneiro, et al.
Published: (2021-11-01)

Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States
by: Alexis Ogdie, et al.
Published: (2020-01-01)

Modulatory Impact of Adipose-Derived Mesenchymal Stem Cells of Ankylosing Spondylitis Patients on T Helper Cell Differentiation
by: Ewa Kuca-Warnawin, et al.
Published: (2021-01-01)

Role of secukinumab in ankylosing spondylitis with tubercular uveitis
by: Padmamalini Mahendradas, et al.
Published: (2020-01-01)

The association between psoriatic arthritis and venous thromboembolism: a population-based cohort study
by: Tal Gazitt, et al.
Published: (2022-01-01)

Direct anti-proliferative effect of adipose-derived mesenchymal stem cells of ankylosing spondylitis patients on allogenic CD4+ cells
by: Ewa Kuca-Warnawin, et al.
Published: (2021-02-01)

Advances of Genomic Medicine in Psoriatic Arthritis
by: Carlos M. Laborde, et al.
Published: (2022-01-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
by: Viola Sacchi, et al.
Published: (2010-06-01)

Cardiovascular risk in psoriatic arthritis
by: V V Badokin, et al.
Published: (2009-06-01)

Patterns of dyslipidemia in young patients with seronegative spondyloarthropathies without cardiovascular diseases
by: Patrycja Ozdowska, et al.
Published: (2021-11-01)

Histopathology of Psoriatic Arthritis Synovium—A Narrative Review
by: Catarina Tenazinha, et al.
Published: (2022-07-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01)

Diagnostic imaging of psoriatic arthritis. Part II: magnetic resonance imaging and ultrasonography
by: Iwona Sudoł-Szopińska, et al.
Published: (2016-06-01)

Perspectives on the Genetic Associations of Ankylosing Spondylitis
by: B. Paul Wordsworth, et al.
Published: (2021-03-01)

Evaluating the Impact of High Intensity Interval Training on Axial Psoriatic Arthritis Based on MR Images
by: Ioanna Chronaiou, et al.
Published: (2022-06-01)

Short-term Efficacy and Safety of Secukinumab in Pakistani Patients with Ankylosing Spondylitis and Psoriatic Arthritis
by: Sumera Ghani, et al.
Published: (2023-06-01)

Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis
by: Dennis McGonagle, et al.
Published: (2021-03-01)

The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis
by: Zarema R. Khismatullina, et al.
Published: (2021-04-01)

IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients
by: Milena Iwaszko, et al.
Published: (2021-06-01)

Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
by: Vandana Bhushan, et al.
Published: (2021-09-01)

Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
by: Ehab F. Girbash, et al.
Published: (2023-01-01)

Targeted Therapies in Psoriatic Arthritis—An Update
by: Sonia Sundanum, et al.
Published: (2023-03-01)

Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
by: Fabiola Atzeni, et al.
Published: (2021-08-01)

Search for genetic markers of predisposition to psoriasis and psoriatic arthritis
by: M. V. Smolnikova, et al.
Published: (2020-12-01)

IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01)

Ankylosing Spondylitis: A Review
by: Farrouq Mahmood, et al.
Published: (2017-11-01)

Longitudinal profiling of the gut microbiome in patients with psoriatic arthritis and ankylosing spondylitis: a multicentre, prospective, observational study
by: Jesus Miguens Blanco, et al.
Published: (2020-11-01)

Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study
by: Muhammad Haroon, et al.
Published: (2018-04-01)

Psoriatic erythroderma: comparative patient profile and association with psoriatic arthritis
by: Elena V. Bogdanova
Published: (2023-01-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
by: M. Elaine Husni, et al.
Published: (2022-03-01)

Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study
by: Chonachan Petcharat, et al.
Published: (2021-04-01)

The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study
by: Chia-Jung Tsai, et al.
Published: (2023-09-01)

Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
by: Ingrid Hokstad, et al.
Published: (2022-12-01)

ENTHESITIS AND PSORIATIC ONYCHOPATHY AS A FACTOR FOR PREDICTION OF PSORIATIC ARTHRITIS IN PSORIASIS
by: Tatyana G. Sidorcika, et al.
Published: (2018-04-01)

The Risk and Predictors of Malignancies in Ankylosing Spondylitis Patients in Israel—A Retrospective Electronic Data-Based Study
by: Polina Kagan, et al.
Published: (2023-08-01)

Nail disease in psoriatic arthritis. Data from the Russian Psoriatic Arthritis Registry
by: E. E. Gubar, et al.
Published: (2021-10-01)

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
by: Colombo GL, et al.
Published: (2018-08-01)